Cargando…

Potential for Developing Plant-Derived Candidate Vaccines and Biologics against Emerging Coronavirus Infections

The emerging human coronavirus infections in the 21st century remain a major public health crisis causing worldwide impact and challenging the global health care system. The virus is circulating in several zoonotic hosts and continuously evolving, causing occasional outbreaks due to spill-over event...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shanmugaraj, Balamurugan, Siriwattananon, Konlavat, Malla, Ashwini, Phoolcharoen, Waranyoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400130/ https://www.ncbi.nlm.nih.gov/pubmed/34451516 http://dx.doi.org/10.3390/pathogens10081051

Ejemplares similares

Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2020)

Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations
por: Siriwattananon, Konlavat, et al.
Publicado: (2021)

Harnessing the Potential of Plant Expression System towards the Production of Vaccines for the Prevention of Human Papillomavirus and Cervical Cancer
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2
por: Siriwattananon, Konlavat, et al.
Publicado: (2021)

Plant-Produced Anti-Enterovirus 71 (EV71) Monoclonal Antibody Efficiently Protects Mice Against EV71 Infection
por: Rattanapisit, Kaewta, et al.
Publicado: (2019)

Biotechnological Insights on the Expression and Production of Antimicrobial Peptides in Plants
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2021)

SARS‐CoV‐2 omicron variant: Could it be another threat?
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana
por: Rattanapisit, Kaewta, et al.
Publicado: (2020)

Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2020)

Development of SARS-CoV-2 neutralizing antibody detection assay by using recombinant plant-produced proteins
por: Jirarojwattana, Perawat, et al.
Publicado: (2023)

Immunogenicity and efficacy of recombinant subunit SARS-CoV-2 vaccine candidate in the Syrian hamster model
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Structural and In Vitro Functional Analyses of Novel Plant-Produced Anti-Human PD1 Antibody
por: Rattanapisit, Kaewta, et al.
Publicado: (2019)

A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques
por: Khorattanakulchai, Narach, et al.
Publicado: (2022)

Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates
por: Siriwattananon, Konlavat, et al.
Publicado: (2021)

Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2020)

Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies
por: Rattanapisit, Kaewta, et al.
Publicado: (2021)

Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Rapid transient expression of functional human vascular endothelial growth factor in Nicotiana benthamiana and characterization of its biological activity
por: Bulaon, Christine Joy I., et al.
Publicado: (2020)

Expression optimization, purification and in vitro characterization of human epidermal growth factor produced in Nicotiana benthamiana
por: Hanittinan, Oranicha, et al.
Publicado: (2020)

Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis
por: Rattanapisit, Kaewta, et al.
Publicado: (2021)

Plant-Produced S1 Subunit Protein of SARS-CoV-2 Elicits Immunogenic Responses in Mice
por: Panapitakkul, Chalisa, et al.
Publicado: (2022)

Efficient Transient Expression of Recombinant Proteins Using DNA Viral Vectors in Freshwater Microalgal Species
por: Malla, Ashwini, et al.
Publicado: (2021)

Expression and Functional Evaluation of Recombinant Anti-receptor Activator of Nuclear Factor Kappa-B Ligand Monoclonal Antibody Produced in Nicotiana benthamiana
por: Boonyayothin, Wanuttha, et al.
Publicado: (2021)

Feasibility of plant-expression system for production of recombinant anti-human IgE: An alternative production platform for therapeutic monoclonal antibodies
por: Hanittinan, Oranicha, et al.
Publicado: (2022)

Metabolic Engineering of Isoflavonoid Biosynthesis by Expressing Glycine max Isoflavone Synthase in Allium cepa L. for Genistein Production
por: Malla, Ashwini, et al.
Publicado: (2020)

Production of Genistein in Amaranthus tricolor var. tristis and Spinacia oleracea by Expression of Glycine max Isoflavone Synthase
por: Malla, Ashwini, et al.
Publicado: (2021)

Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant
por: Phoolcharoen, Waranyoo, et al.
Publicado: (2023)

Effect of plant produced Anti-hIL-6 receptor antibody blockade on pSTAT3 expression in human peripheral blood mononuclear cells
por: Kaewbandit, Namthip, et al.
Publicado: (2023)

Author Correction: Effect of plant produced Anti-hIL-6 receptor antibody blockade on pSTAT3 expression in human peripheral blood mononuclear cells
por: Kaewbandit, Namthip, et al.
Publicado: (2023)

Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application
por: Boonyayothin, Wanuttha, et al.
Publicado: (2022)

Electrochemical paper-based antigen sensing platform using plant-derived monoclonal antibody for detecting SARS-CoV-2
por: Jaewjaroenwattana, Jutamas, et al.
Publicado: (2023)

Expression of plant-produced anti-PD-L1 antibody with anoikis sensitizing activity in human lung cancer cells via., suppression on epithelial-mesenchymal transition
por: Phetphoung, Thareeya, et al.
Publicado: (2022)

Efficiency Comparative Approach of Plant-Produced Monoclonal Antibodies against Rabies Virus Infection
por: Lumlertdacha, Boonlert, et al.
Publicado: (2023)

Functional Characterization of Pembrolizumab Produced in Nicotiana benthamiana Using a Rapid Transient Expression System
por: Phakham, Tanapati, et al.
Publicado: (2021)

In vitro and in vivo studies of plant-produced Atezolizumab as a potential immunotherapeutic antibody
por: Rattanapisit, Kaewta, et al.
Publicado: (2023)

Plant-produced recombinant Osteopontin-Fc fusion protein enhanced osteogenesis
por: Rattanapisit, Kaewta, et al.
Publicado: (2019)

Artificial intelligence-driven systems engineering for next-generation plant-derived biopharmaceuticals
por: Parthiban, Subramanian, et al.
Publicado: (2023)

Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites
por: Sakamoto, Seiichi, et al.
Publicado: (2017)

Correction to: Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites
por: Sakamoto, Seiichi, et al.
Publicado: (2018)

Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses
por: Venkataraman, Srividhya
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u4miee21h325d2tsr8bvs1u6ro